Member Info for EmeraldCarrots

15% Up for starters.

Will happen.............

All IMHO.

I don't think Angle will have any finance issues. LOL!!!!

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

Massive news.

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

Sales of Parsortix machines and Angle's services using their bank of machines are going to rocket IMHO.

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

Of people's limits will be hit with them unaware of this very very significant announcement. Shame. The sp IMHO will be North of 18p today and move up from there...........

All IMHO.

Using Illumina assay". ******* M A S S I V E ********** >>>>>>>>>>>>>>>> !!!!!!!!!!!!!!!!!!

https://www.lse.co.uk/rns/AGL/analysis-of-ctc-dna-and-ctdna-using-illumina-assay-mqynkijrkyza9ga.html

Just join the dots............... Angle Plc offer HER2 analysis from a standard blood sample.......

https://www.londonstockexchange.com/news-article/AZN/enhertu-approved-in-us-for-breast-cancer-post-et/16871848

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-astrazeneca-edeymgqdtcshqde.html

https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-large-pharma-gvzk9wgh1la0ljx.html

IMHO, and if they do Illumina, Eisai and others will come ourt of the woodwork. Seems extremely likely so me.

Any bid would have to be 60p a share plus to have any chance.

Happy days!

https://www.londonstockexchange.com/news-article/AZN/enhertu-approved-in-us-for-breast-cancer-post-et/16871848

All IMHO.

Cancer post ET.". We offer HER2 expression analysis from a std tube of blood!!!!

https://www.londonstockexchange.com/news-article/AZN/enhertu-approved-in-us-for-breast-cancer-post-et/16871848

All IMHO.

Level. One happy to sell and one happy to buy. Suspect big new investor is the buyer, TR-1 on the cards.

All IMHO.

Or was it a buy from last week? No way of knowing. Huge trades don't have to be shown for up to 10 days. This is why the bid/ask can sometimes leap up or down when no trades at all have happened in the prev hour etc.......

Mean more research into this potential way of slowing down cancer spread. They used Angle's Parsortix machine to select the people with circulating tumour cells (CTC's) that had clustered together in the blood stream before the study. Clearly Angle are extremely likely to either sell more of the Parsortix machines or be contracted themselves to analyse the blood samples during cancer drug trials of this nature.

https://www.lse.co.uk/rns/AGL/parsortix-used-in-research-paper-from-eth-zurich-vzjld2rwf1kvxgm.html

All IMHO.

Existing one upping their holding or new one building a stake. The trades speak for themselves.

All IMHO.

Cancer drug trials on Digoxin and/or some of the other similar drugs they have bought the rights to use in this way (breaking up CTC clusters). No doubt some of the biggest players in the market will be very interested in this. Angle will be used to monitor the clusters during these trials to find out how effective they are at breaking them up. Thus, I think we can look forward to working with at least one other Pharma Co. similar in size to Astrazeneca and Eisai.

All IMHO.

It seems to me Angle need to set up a service to test blood samples to see if CTC clusters are present in a cancer patients blood. Giving this information can't be against any rules, surely. It is simple examining a standard blood sample. Then whoever paid for the test can do what they want. If they find a doctor is allowed to administer Digoxin then good luck to them!

All IMHO.

Person who has a cancer that is spreading could not pay to have Angle test their std blood sample to see if CTC clusters are present? Onlt a std blood sample is needed after all. Then if they are ask their doctor to treat them with Digoxin? Digoxin is already approved is it not?

Could get interesting!

All IMHO.

Have been contracted to monitor the size of circulating tumour cell clusters before, during and after drug trials involving these "cluster buster" drugs. The Page Therapeutics study utilising Digoxin to do this opens the door to loads more drug trials. Breaking up clusters of CTC (circulating tumour cells) almost certainly improves a cancer patients outlook. Page Therapeutics chose Angle's Parsortix machine for the study and it is highly likely they and their competitors will use it in future cancer drug trials. I suspect Angle will be standing on their own 2 feet within 12 months without the need for more cash.

I don’t see how they won’t get significant drug trial contracts involving this.

All IMHO.

CTC clusters has done the trick. Sp breaking out, about time!!

Correction. "drug TRIALS".

Breaking up clusters of CTC (circulating tumour cells) almost certainly improves a cancer patients outlook is significant for Angle. Page Therapeutics chose Angle's Parsortix machine for the study and it is highly likely they and their competitors will use it in future cancer drug TRIALS. I suspect Angle will be standing on their own 2 feet within 12 months without the need for more cash.

All IMHO.